| scholarly article | Q13442814 |
| P2093 | author name string | Jeremy Turlington | |
| Lisa Brath | |||
| Michael Sternberg | |||
| Markos G Kashiouris | |||
| Michael L'Heureux | |||
| P2860 | cites work | Pulmonary artery catheters for adult patients in intensive care | Q24245010 |
| The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 | ||
| A review of sepsis-induced cardiomyopathy | Q26777219 | ||
| Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
| Pathophysiology of sepsis-induced myocardial dysfunction | Q28079058 | ||
| Trial of Early, Goal-Directed Resuscitation for Septic Shock | Q30053759 | ||
| Acute Noncardiovascular Illness in the Cardiac Intensive Care Unit | Q30252580 | ||
| Severity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis | Q30317801 | ||
| Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications | Q30318473 | ||
| Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS). | Q30383657 | ||
| Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression | Q31157664 | ||
| Goal-directed resuscitation for patients with early septic shock | Q34441276 | ||
| Outcome prediction in sepsis: speckle tracking echocardiography based assessment of myocardial function | Q34485604 | ||
| A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. | Q34721360 | ||
| Yohimbine Promotes Cardiac NE Release and Prevents LPS-Induced Cardiac Dysfunction via Blockade of Presynaptic α2A-Adrenergic Receptor | Q34730803 | ||
| Protective effect of erythropoietin against myocardial injury in rats with sepsis and its underlying mechanisms | Q35201722 | ||
| Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity? | Q35764104 | ||
| Early dynamic left intraventricular obstruction is associated with hypovolemia and high mortality in septic shock patients | Q35908257 | ||
| Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: A comparative retrospective study | Q52622851 | ||
| Association between relative adrenal insufficiency and septic cardiomyopathy: a preliminary report | Q54099131 | ||
| Sepsis in European intensive care units: results of the SOAP study | Q54471944 | ||
| Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. | Q54940493 | ||
| Effect of prone positioning on the survival of patients with acute respiratory failure. | Q55035126 | ||
| α2A-adrenergic blockade attenuates septic cardiomyopathy by increasing cardiac norepinephrine concentration and inhibiting cardiac endothelial activation. | Q55339088 | ||
| Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database | Q56366375 | ||
| Sulfur dioxide attenuates sepsis-induced cardiac dysfunction via inhibition of NLRP3 inflammasome activation in rats | Q57067436 | ||
| Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis | Q58800574 | ||
| Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper | Q60950194 | ||
| The glycocalyx: a novel diagnostic and therapeutic target in sepsis | Q61446862 | ||
| Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan | Q63464486 | ||
| Use of 2-dimensional speckle-tracking echocardiography to assess left ventricular systolic function in dogs with systemic inflammatory response syndrome | Q64276661 | ||
| Myocardial Strain and Cardiac Output are Preferable Measurements for Cardiac Dysfunction and Can Predict Mortality in Septic Mice. | Q64974422 | ||
| Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock | Q69746767 | ||
| Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases | Q72838812 | ||
| An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure | Q73028228 | ||
| A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock | Q73222186 | ||
| Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis* | Q84603543 | ||
| Protocol-based care for early septic shock | Q87431242 | ||
| Global Longitudinal Strain Using Speckle-Tracking Echocardiography as a Mortality Predictor in Sepsis: A Systematic Review | Q88094392 | ||
| Alpha-1 Adrenergic Receptor Agonist Phenylephrine Inhibits Sepsis-Induced Cardiomyocyte Apoptosis and Cardiac Dysfunction via Activating ERK1/2 Signal Pathway | Q89062823 | ||
| Impact of Point-of-Care Ultrasound in the Emergency Department on Care Processes and Outcomes in Critically Ill Nontraumatic Patients | Q90286360 | ||
| Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial | Q90410470 | ||
| Risk Factors for New-Onset Atrial Fibrillation in Patients With Sepsis: A Systematic Review and Meta-Analysis | Q91088883 | ||
| The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications | Q91256777 | ||
| Scientific Letter to the Editor: Need for a Definitive Study of Global Longitudinal Strain for Prognostication in Septic Cardiomyopathy | Q91435760 | ||
| A decade of progress in critical care echocardiography: a narrative review | Q92618782 | ||
| Myocardial Edema: an Overlooked Mechanism of Septic Cardiomyopathy? | Q92979690 | ||
| Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis | Q93345977 | ||
| Diastolic dysfunction and mortality in severe sepsis and septic shock | Q35937776 | ||
| Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock | Q36748926 | ||
| Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression | Q36955252 | ||
| Fever-induced Brugada pattern: how common is it and what does it mean? | Q37321655 | ||
| Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study | Q37605966 | ||
| Bench-to-bedside review: Beta-adrenergic modulation in sepsis. | Q37623067 | ||
| Ejection fraction revisited | Q37623549 | ||
| Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy | Q37943123 | ||
| Echocardiographic hemodynamic monitoring in the critically ill patient | Q38023553 | ||
| Prognostic value of troponins in sepsis: a meta-analysis. | Q38099774 | ||
| A review of methylene blue treatment for cardiovascular collapse | Q38186349 | ||
| International consensus statement on training standards for advanced critical care echocardiography | Q38194958 | ||
| Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial | Q38443276 | ||
| Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials | Q38533057 | ||
| Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock | Q38869290 | ||
| Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. | Q39029084 | ||
| Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study | Q40051663 | ||
| Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. | Q40367577 | ||
| The protective role of neuregulin-1: A potential therapy for sepsis-induced cardiomyopathy | Q40635840 | ||
| Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis | Q40657906 | ||
| Impact of Dobutamine in Patients With Septic Shock: A Meta-Regression Analysis | Q40748583 | ||
| Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock | Q40908825 | ||
| Circulating Histones Are Major Mediators of Cardiac Injury in Patients With Sepsis. | Q41134828 | ||
| Evaluation of left ventricular systolic function revisited in septic shock. | Q42176944 | ||
| The influence of methylene blue infusion on cytokine levels during severe sepsis. | Q42435081 | ||
| Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study | Q42556582 | ||
| Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome | Q42871311 | ||
| Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes | Q43504359 | ||
| Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. | Q43545711 | ||
| Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis | Q43707142 | ||
| Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study | Q43757721 | ||
| Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats | Q43995613 | ||
| Attenuation of sepsis-induced organ injury in mice by vitamin C. | Q44208591 | ||
| Profound but reversible myocardial depression in patients with septic shock | Q44250178 | ||
| Usefulness of heart-type fatty acid–binding protein in patients with severe sepsis | Q44950294 | ||
| Association between inotrope treatment and 90-day mortality in patients with septic shock | Q45075848 | ||
| Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit | Q46925063 | ||
| Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice | Q47141022 | ||
| Septic Cardiomyopathy | Q47222126 | ||
| Tissue Doppler assessment of diastolic function and relationship with mortality in critically ill septic patients: a systematic review and meta-analysis. | Q47232771 | ||
| An experimental study of the protective effect of simvastatin on sepsis-induced myocardial depression in rats | Q47800200 | ||
| Reducing Elevated Heart Rates in Patients with Multiple Organ Dysfunction Syndrome with the If (Funny Channel Current) Inhibitor Ivabradine | Q49989577 | ||
| Methylene Blue for Acute Septic Cardiomyopathy in a Burned Patient | Q50216192 | ||
| Bacteremia due to gram-negative bacilli other than the Salmonella; a clinical and therapeutic study | Q50512049 | ||
| Elevation of systemic oxygen delivery in the treatment of critically ill patients | Q51631613 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 35 | |
| P577 | publication date | 2020-05-06 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Sepsis-Induced Cardiomyopathy: a Comprehensive Review | |
| P478 | volume | 22 |
Search more.